NEWS & ANNOUNCEMENTS ARCHIVE

HASHTAG SEARCH: #study


BACK TO NEWS
News Story Friday, June 04, 2021

Interesting study on why some diabetics don't take their medication.

Several barriers to metformin adherence and persistence—included delays in accepting the diagnosis of type 2 diabetes; the cost of visiting a doctor and prescription charges; complex and busy lives; and feelings of guilt and shame about having diabetes and/or poor control of blood sugars that prevented people from visiting their doctor.

Participants' comments highlighted the importance of developing and maintaining good patient/healthcare provider relationships and tailoring communication styles to the preferences of patients.

See the article here.
https://bit.ly/3cgdeoe

#study#news


News Story Monday, April 12, 2021

Studies assessing adherence to chronic medications have reported an average adherence rate of 50%.

Medication nonadherence remains an unresolved public health issue in the United States and is a significant source of morbidity, mortality, and increased healthcare costs for patients with chronic disease states.

Studies assessing adherence to chronic medications have reported an average adherence rate of 50%.

Failure to adhere to prescribed medication regimens costs the US health care system more than $100 billion each year for otherwise avoidable hospitalizations.

See study here

https://bit.ly/3s5G2Fa

#study#news


News Story Friday, October 23, 2020

Prime Therapeutics researchers studied hypertension, cholesterol and diabetes medications. See the results here.

They found with a population of over 567,000, sample sizes for each drug category and their associated total cost of care savings – from moving someone with low adherence (<50%) to near perfect adherence (99%+) – was as follows:
- RAS: 132,358 in the sample, achieving $2,901 potential savings PPPY
- Statin: 145,038 in the sample, achieving $1,563 potential savings PPPY
- Diabetes: 40,407 in the sample, achieving $3,365 potential savings PPPY
Additionally, the study found lower odds of hospitalizations and emergency room visits were associated with improved drug category adherence.
https://yhoo.it/2ISbiXa

#primetherapeutics#study#hypertension#cholesterol#diabetes


News Story Friday, May 29, 2020

SenecaGlobal and DayaMed create a radically new medical software.

Check out our newest healthcare software case study. CLICK HERE

#senecaglobal#dayamed#casestudy



DAYAMED EXECUTIVE TEAM

SOCIAL MEDIA

Copyright © 2021 Daya Medicals Inc. | PRIVACY | SITEMAP